A new certification has been launched to promote responsible antibiotic manufacturing and combat antimicrobial resistance. The certification, developed by the UK standards body BSI In verifies that waste streams containing antibiotic-active pharmaceutical ingredients and drug products are appropriately controlled during manufacturing.
After the initial evaluation, antibiotic manufacturers globally will be eligible for certification. Pfizer, Roche, Sandoz, and Teva are among the first market achievers to participate in a pilot program supporting antibiotic waste control measures. The World Health Organization estimates bacterial AMR caused 4.95 million deaths in 2019.
Department of Health Abu Dhabi has partnered with Mass General Brigham‘s International Center for Genetic Disease to advance genomics research, develop therapies, and improve healthcare outcomes 🌍🔬. Joint labs and genetic screening programs will address global genetic diseases and reinforce Abu Dhabi as a leading healthcare and life sciences destination 🏥💉.
AstraZeneca 🏭 will use biogas made from cow manure and food waste 🍴 to cut emissions in its U.S. sites. The deal with Vanguard Renewables 💰 will produce as much energy 💡 as heating 17,800 homes 🏠 a year. The company aims to reduce emissions 🌍 by 98% 📉 by 2026.
field ablation devices from Boston Scientific, Johnson & Johnson, and Medtronic threaten Abbott’s $1.9 billion electrophysiology business. Abbott is cautious about PFA and plans to release a later-generation device. Analysts predict potential losses for Abbott as PFA takes over 90% of electrophysiology sales by 2025. 💼💉💰
GSK and Fizer have FDA-approved RSV vaccines. 💉 GSK’s Arexvy is the first in the EU, but Pfizer’s Abrysvo targets multiple patient segments and is under review as a maternal vaccine. 💊 Moderna‘s mRNA-1345 is also expected to enter the market and may be better at targeting new viral strains. 🌡️
🚀 Samsung Biologics and Pfizer are partnering to improve biopharmaceutical manufacturing and deliver life-saving treatments worldwide. Samsung Biologics will provide additional capacity through their Plant 4 facility, supporting oncology, inflammation, and immunology therapeutic areas. 💊💉🌍
🔬 Researchers from The Chinese University of Hong Kong have found that neutrophils, a type of immune cell, play a role in lung cancer. Using gene editing technology, the team enhanced the anticancer capacity of neutrophils and tested their potential on lung cancer models.
The study has led to the first patented invention using gene engineering to mass-produce anticancer neutrophils from human blood, revealing the possibility of developing neutrophils into a novel immunotherapy for solid cancers. 💪
Seattle Children’s Hospital has stopped testing an experimental cancer cell therapy from 2Seventy Bio after a participant died during the early-stage clinical trial. The company has paused the PLAT-08 trial while investigating the cause of death and its potential link to the treatment made from patient T cells. 2Seventy’s chief medical officer said patient safety is their top priority, and they are assessing data and potential next steps with the FDA.
Ali Saad Agency for Translation Services is a difference maker in Arabic Translation Services. Our translation business is legally registered as a sole proprietorship in Egypt under Tax Reg. No. 536-002-304.